IVIM Health vs LifeMD

IVIM Health vs LifeMD at every dose

A single headline figure assumes a maintenance dose neither you nor your prescriber has chosen yet. This is the same comparison at all six strengths.

What differs beyond price

Price is the easiest thing to compare and rarely the thing that decides satisfaction. These are the attributes each programme publishes.

Which one, for whom

If you want the lowest total cost: IVIM Health at about $3,219 for a first year.

If you want budget certainty: LifeMD, which holds one price at every strength.

If you want to verify the supply chain: neither names a dispensing pharmacy in a way we could verify — ask both directly.

If you may need to stop early: compare the cancellation rows above before prepaying. Compounded medication is generally not refundable once it has shipped, so a multi-month term is the wrong structure during titration, when intolerance is the most likely reason to stop.

Switching between them

Usually possible after a clinical review, and the two real risks are a supply gap while a new intake is processed and a new prescriber restarting titration rather than continuing your dose. Confirm dose continuity in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.

If you are already on one of them

Moving from LifeMD to IVIM Health is worth $3,945 over a year. Set that against two real switching costs: a gap in supply while a new intake is reviewed, and the possibility that a new prescriber restarts titration rather than continuing your dose. Ask about dose continuation in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.

Fee structure, side by side

IVIM Health charges a mandatory membership of $75 a month on top of medication. LifeMD charges a mandatory membership of $149 a month.

This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.

Care model and what it buys

IVIM Health: video, labs required, included. LifeMD: video, labs required, included.

Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.

Verification, which outranks both

IVIM Health: not named. LifeMD: not named.

A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.

Which is cheaper depends on where you land

A single annual comparison assumes one maintenance dose. This runs both programmes at every plausible outcome, over one year and three.

Read the final column before the first. A gap that looks modest over twelve months compounds into the three-year figure, and the withdrawal evidence for this drug class means three years is the more honest planning horizon.

What each one is actually charging for

IVIM Health: $203 medication plus $75 platform fee, $900 a year. LifeMD: $448 medication plus $149 platform fee, $1,788 a year.

Comparing the medication figures alone would make LifeMD look $74 a month cheaper than it is. That is the single most common distortion in published comparisons of these two.

Where the money actually separates

A single annual figure hides when the gap opens. Tracked month by month through a first year you can see whether the difference is front-loaded during titration or accumulates quietly at maintenance.

Across the year the gap reaches $3,945, roughly 55% of the larger total and about 14.2 months of therapy at IVIM Health's maintenance rate. Over three years at a stable dose the same difference compounds to roughly $11,484.

Does the answer change with your dose?

IVIM Health is cheaper at every strength, so this comparison does not turn on where you settle. The decision moves to what else differs: disclosure, care model, commitment terms and behaviour when a shipment fails.

Commitment and what each puts at risk

IVIM Health publishes no prepaid term. LifeMD publishes no prepaid term.

Prepaying lowers the rate and makes the money effectively unrecoverable, because compounded medication is generally not refundable once shipped. During titration that is the wrong structure: it commits against the most likely reason to stop. After a stable cycle at maintenance it is reasonable.

Care model and what you can verify

IVIM Health: video, labs required, pharmacy not named, cancellation membership mandatory.

LifeMD: video, labs required, pharmacy not named, cancellation membership recurring.

Where one names a pharmacy and the other does not, that difference outranks a modest price gap. It is the only disclosure that lets you check a public register before injecting something weekly, and it costs a programme nothing to publish.

If you are already on one of them

Moving from LifeMD to IVIM Health is worth $3,945 over a year, about 14.2 months of therapy at the cheaper rate. Set that against two real switching costs: a supply gap while an intake is reviewed, and the possibility that a new prescriber restarts titration.

Ask about dose continuation in writing before cancelling anything. A month back at 2.5 mg is a month of lost progress that no price difference recovers, and it is the most common regret reported by people who switched for a small saving.

What neither table can tell you

Shipping reliability, how fast a clinician actually replies, whether a dose adjustment takes two days or two weeks, and what happens when a cold-chain shipment fails. Those decide satisfaction more than price does, and we hold no measurements of them we would defend, so they are absent rather than estimated.

The one usable proxy is what each programme publishes before it has your money. A programme that states its price at every dose, names its pharmacy and puts cancellation terms in writing has already told you something about how it behaves when there is a problem.

Running this comparison again later

Both figures carry a capture date and both will change. Programmes do not notify existing patients when a competitor drops below them, and several tracked programmes moved pricing more than once in the past year.

Re-run this at your actual maintenance dose annually, and treat any figure older than a month as needing a re-check before you act on it.

Where both of these sit in the wider market

IVIM Health at $3,219 and LifeMD at $7,164 for a first year sit against a market running from $2,580 to $7,164. At least one of them sits above the midpoint of what we track, which is worth knowing before treating this pairing as a shortlist.

If neither is close to the cheapest tracked route, the useful question is not which of these two wins but why you are choosing between these two at all. The comparison matrix will show what else is available at your dose in about ten seconds.

If you are already on one of them

Moving from LifeMD to IVIM Health is worth $3,945 over a year. Set that against two real switching costs: a gap in supply while a new intake is reviewed, and the possibility that a new prescriber restarts titration rather than continuing your dose. Ask about dose continuation in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.

Fee structure, side by side

IVIM Health charges a mandatory membership of $75 a month on top of medication. LifeMD charges a mandatory membership of $149 a month.

This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.

Care model and what it buys

IVIM Health: video, labs required, included. LifeMD: video, labs required, included.

Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.

Verification, which outranks both

IVIM Health: not named. LifeMD: not named.

A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.

Which is cheaper depends on where you land

A single annual comparison assumes one maintenance dose. This runs both programmes at every plausible outcome, over one year and three.

Read the final column before the first. A gap that looks modest over twelve months compounds into the three-year figure, and the withdrawal evidence for this drug class means three years is the more honest planning horizon.

What each one is actually charging for

IVIM Health: $203 medication plus $75 platform fee, $900 a year. LifeMD: $448 medication plus $149 platform fee, $1,788 a year.

Comparing the medication figures alone would make LifeMD look $74 a month cheaper than it is. That is the single most common distortion in published comparisons of these two.

The gap between IVIM Health and LifeMD

IVIM Health costs $319 a month less than LifeMD at a 10 mg maintenance dose — $278 against $597 — which compounds to $3,945 across a first year, a 55% difference.

Both dispense the same molecule. The gap is overhead, clinical wrap, pharmacy sourcing and margin, not a difference in what arrives in the vial.

Flat against dose-scaled

This is the structural difference that matters here. LifeMD holds one price across the whole 2.5—15 mg ladder; IVIM Health reprices as you climb, from $208 at the starter dose to $325 at 15 mg.

The comparison therefore changes depending on where you settle. At a low maintenance dose IVIM Health can win; at 15 mg LifeMD wins by $272 a month. Nobody knows which applies at signup, which is the honest summary of this pair.

Only one of these also offers semaglutide

IVIM Health dispenses compounded semaglutide at $224 a month alongside its tirzepatide offering. LifeMD does not publish a semaglutide price we could capture.

That matters if you are not yet committed to a molecule. Starting on semaglutide and moving to tirzepatide later is a common path, and doing it inside one programme avoids a second intake, a second clinician relationship and a second pharmacy. Switching molecules is not a dose conversion in any case: tirzepatide restarts at 2.5 mg and titrates from the bottom regardless of the semaglutide dose reached.

Pharmacy disclosure on both sides

Neither programme names the dispensing pharmacy before purchase, so neither can be checked independently in advance. Ask in writing which pharmacy fills the prescription and whether it is a 503A or 503B facility.